6-158158343-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_032861.4(SERAC1):c.21C>A(p.Cys7*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_032861.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial oxidative phosphorylation disorder Pathogenic:1
The p.Cys7X (NM_032861.3 c.21C>A) variant in SERAC1 has not been previously repo rted in the literature and was absent from large population studies. This nonsen se variant leads to a premature termination codon at position 7, which is predic ted to lead to a truncated or absent protein. Biallelic loss of function of the SERAC1 gene has been associated with 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL syndrome), also referred to as 3-methylglutaconic aciduria type VI (MGCA6). In summary, although additional stu dies are required to fully establish a null effect on the protein, the p.Cys7X v ariant in the SERAC1 gene is likely pathogenic for MEGDEL syndrome in an autosom al recessive manner based on its predicted impact on the protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at